Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Peer Christiansen"'
Autor:
Trine Tramm, Stephen Hamilton-Dutoit, James W. Baurley, Kristina Lystlund Lauridsen, Per Damkier, Anders Kjærsgaard, Peer Christiansen, Lindsay J Collin, Kristina B. Christensen, Maret L. Maliniak, Rebecca A. Silliman, Deirdre Cronin-Fenton, Timothy L. Lash, Michael E. Zwick, Thomas P. Ahern, Bent Ejlertsen, R. Benjamin Isett, Rebecca Nash, Henrik Toft Sørensen
Publikováno v:
Ahern, T P, Collin, L J, Baurley, J W, Kjærsgaard, A, Nash, R, Maliniak, M L, Damkier, P, Zwick, M E, Isett, R B, Christiansen, P M, Ejlertsen, B, Lauridsen, K L, Christensen, K, Silliman, R A, Toft Sørensen, H, Tramm, T, Hamilton-Dutoit, S, Lash, T L & Cronin-Fenton, D 2020, ' Metabolic Pathway Analysis and Effectiveness of Tamoxifen in Danish Breast Cancer Patients ', Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, vol. 29, no. 3, pp. 582-590 . https://doi.org/10.1158/1055-9965.EPI-19-0833
Ahern, T P, Collin, L J, Baurley, J W, Kjærsgaard, A, Nash, R, Maliniak, M L, Damkier, P, Zwick, M E, Isett, R B, Christiansen, P M, Ejlertsen, B, Lauridsen, K L, Christensen, K B, Silliman, R A, Toft Sorensen, H, Tramm, T, Hamilton-Dutoit, S, Lash, T L & Cronin Fenton, D 2020, ' Metabolic pathway analysis and effectiveness of tamoxifen in Danish breast cancer patients ', Cancer Epidemiology, Biomarkers & Prevention, vol. 29, no. 3, pp. 582-590 . https://doi.org/10.1158/1055-9965.EPI-19-0833
Cancer Epidemiol Biomarkers Prev
Ahern, T P, Collin, L J, Baurley, J W, Kjærsgaard, A, Nash, R, Maliniak, M L, Damkier, P, Zwick, M E, Isett, R B, Christiansen, P M, Ejlertsen, B, Lauridsen, K L, Christensen, K B, Silliman, R A, Toft Sorensen, H, Tramm, T, Hamilton-Dutoit, S, Lash, T L & Cronin Fenton, D 2020, ' Metabolic pathway analysis and effectiveness of tamoxifen in Danish breast cancer patients ', Cancer Epidemiology, Biomarkers & Prevention, vol. 29, no. 3, pp. 582-590 . https://doi.org/10.1158/1055-9965.EPI-19-0833
Cancer Epidemiol Biomarkers Prev
Background: Tamoxifen and its metabolites compete with estrogen to occupy the estrogen receptor. The conventional dose of adjuvant tamoxifen overwhelms estrogen in this competition, reducing breast cancer recurrence risk by nearly half. Phase I metab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1801d69fb5cd7b94c2ec62c58bf25321
https://findresearcher.sdu.dk:8443/ws/files/162520147/1055_9965.EPI_19_0833.full.pdf
https://findresearcher.sdu.dk:8443/ws/files/162520147/1055_9965.EPI_19_0833.full.pdf
Autor:
Vibeke Jensen, Peer Christiansen, Giedrius Lelkaitis, Sarah Schulz Nielsen, Marianne Djernes Lautrup, Anne Marie Bak Jylling
Publikováno v:
Breast Cancer (Tokyo, Japan)
Jylling, A M B, Jensen, V, Lelkaitis, G, Christiansen, P, Nielsen, S S & Lautrup, M D 2020, ' Male breast cancer : clinicopathological characterization of a National Danish cohort 1980–2009 ', Breast Cancer, vol. 27, no. 4, pp. 683-695 . https://doi.org/10.1007/s12282-020-01066-3
Jylling, A M B, Jensen, V, Lelkaitis, G, Christiansen, P, Nielsen, S S & Lautrup, M D 2020, ' Male breast cancer : clinicopathological characterization of a National Danish cohort 1980–2009 ', Breast Cancer, vol. 27, no. 4, pp. 683-695 . https://doi.org/10.1007/s12282-020-01066-3
Background To describe relevant pathological parameters of Danish male breast cancer patients (MBCP) diagnosed from 1980 to 2009, and to relate these data to treatment, overall survival (OS) and standardized mortality rate (SMR). Materials and method
Autor:
Trine Tramm, Peer Christiansen, Anne Bodilsen, Hanne Melgaard Nielsen, Jonas Amstrup Funder, Anne Schmidt Sorensen, Marco Mele, Josephine Bruun
Publikováno v:
Mele, M, Sørensen, A S, Bruun, J, Funder, J A, Tramm, T, Bodilsen, A, Nielsen, H M & Christiansen, P M 2019, ' Inflammatory breast cancer : A review from our experience ', Breast Disease, vol. 38, no. 2, pp. 47-55 . https://doi.org/10.3233/BD-180365
INTRODUCTION: Inflammatory Breast Cancer (IBC) is a distinct and rare type of breast cancer accounting for up to 6% of all breast cancer cases in Europe. The aim of this study was to investigate diagnostic methods, treatments, and outcome after IBC i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c2fde238c6e05cc881054e1f438ab79
https://pure.au.dk/portal/da/publications/inflammatory-breast-cancer(c3af6599-1a4d-4e37-8e81-962726ba1a64).html
https://pure.au.dk/portal/da/publications/inflammatory-breast-cancer(c3af6599-1a4d-4e37-8e81-962726ba1a64).html
Autor:
Per Damkier, Thomas P. Ahern, Stephen Hamilton-Dutoit, Anders Kjærsgaard, Lindsay J Collin, Peer Christiansen, Kristina B. Christensen, Deirdre Cronin-Fenton, Kristina Lystlund Lauridsen, Timothy L. Lash, Henrik Toft Sørensen, Rami Yacoub
Publikováno v:
Collin, L J, Cronin-Fenton, D P, Ahern, T P, Christensen, K B, Damkier, P, Hamilton-Dutoit, S, Kjaersgaard, A, Lauridsen, K L, Yacoub, R, Christiansen, P, Sørensen, H T & Lash, T L 2019, ' Expression of survivin does not appear to influence breast cancer recurrence risk ', Acta Oncologica, vol. 58, no. 2, pp. 154-161 . https://doi.org/10.1080/0284186X.2018.1503419
BACKGROUND: Survivin is an inhibitor of apoptosis, and its expression associates with poor outcomes in multiple cancers. It may be a therapeutic target due to its unique expression in cancer cells.METHODS: We estimated the association between nuclear
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11c5d4567c22bdcc224bb419fa7029e9
https://pure.au.dk/portal/da/publications/expression-of-survivin-does-not-appear-to-influence-breast-cancer-recurrence-risk(8edf1125-b428-4628-b8be-a770a766d5de).html
https://pure.au.dk/portal/da/publications/expression-of-survivin-does-not-appear-to-influence-breast-cancer-recurrence-risk(8edf1125-b428-4628-b8be-a770a766d5de).html
Autor:
Peer Christiansen, Anne Vibeke Lænkholm, Maj-Britt Jensen, Bent Ejlertsen, Henning T. Mouridsen, Birgitte Vrou Offersen, Niels Kroman
Publikováno v:
Jensen, M-B, Laenkholm, A-V, Offersen, B V, Christiansen, P, Kroman, N, Mouridsen, H T & Ejlertsen, B 2018, ' The clinical database and implementation of treatment guidelines by the Danish Breast Cancer Cooperative Group in 2007-2016 ', Acta Oncologica, vol. 57, no. 1, pp. 13-18 . https://doi.org/10.1080/0284186X.2017.1404638
BACKGROUND:Since 40 years, Danish Breast Cancer Cooperative Group (DBCG) has provided comprehensive guidelines for diagnosis and treatment of breast cancer. This population-based analysis aimed to describe the plurality of modifications introduced ov
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be4495310fe193d81c6b2686b947c3a2
https://pure.au.dk/portal/da/publications/the-clinical-database-and-implementation-of-treatment-guidelines-by-the-danish-breast-cancer-cooperative-group-in-20072016(d4dd5b59-92ee-403d-8beb-ab52f91f919a).html
https://pure.au.dk/portal/da/publications/the-clinical-database-and-implementation-of-treatment-guidelines-by-the-danish-breast-cancer-cooperative-group-in-20072016(d4dd5b59-92ee-403d-8beb-ab52f91f919a).html
Autor:
Karen Haugaard, Susanne Bokmand, Signe S. Thorup, Peer Christiansen, Hjoerdis Joernsgaard, Giedrius Lelkaitis, Marianne Djernes Lautrup, Gro M. Qvamme, Vibeke Jensen, Mette H. Oldenburg, Anne Marie Bak Jylling, Katrine Soee, Inger Hoejris
Publikováno v:
Lautrup, M D, Thorup, S S, Jensen, V, Brokmand, S, Haugaard, K, Hoejris, I, Jylling, A-M B, Joernsgaard, H, Lelkaitis, G, Oldenburg, M H, Qvamme, G M, Soee, K & Christiansen, P 2018, ' Male breast cancer: a nation-wide population-based comparison with female breast cancer ', Acta Oncologica, vol. 57, no. 5, pp. 613-621 . https://doi.org/10.1080/0284186X.2017.1418088
Lautrup, M D, Thorup, S S, Jensen, V, Bokmand, S, Haugaard, K, Hoejris, I, Jylling, A M B, Joernsgaard, H, Lelkaitis, G, Oldenburg, M H, Qvamme, G M, Soee, K & Christiansen, P 2018, ' Male breast cancer : a nation-wide population-based comparison with female breast cancer ', Acta Oncologica, vol. 57, no. 5, pp. 613-621 . https://doi.org/10.1080/0284186X.2017.1418088
Lautrup, M D, Thorup, S S, Jensen, V, Bokmand, S, Haugaard, K, Hoejris, I, Jylling, A-M B, Joernsgaard, H, Lelkaitis, G, Oldenburg, M H, Qvamme, G M, Soee, K & Christiansen, P 2018, ' Male breast cancer : a nation-wide population-based comparison with female breast cancer ', Acta Oncologica, vol. 57, no. 5, pp. 613-621 . https://doi.org/10.1080/0284186X.2017.1418088
Lautrup, M D, Thorup, S S, Jensen, V, Bokmand, S, Haugaard, K, Hoejris, I, Jylling, A M B, Joernsgaard, H, Lelkaitis, G, Oldenburg, M H, Qvamme, G M, Soee, K & Christiansen, P 2018, ' Male breast cancer : a nation-wide population-based comparison with female breast cancer ', Acta Oncologica, vol. 57, no. 5, pp. 613-621 . https://doi.org/10.1080/0284186X.2017.1418088
Lautrup, M D, Thorup, S S, Jensen, V, Bokmand, S, Haugaard, K, Hoejris, I, Jylling, A-M B, Joernsgaard, H, Lelkaitis, G, Oldenburg, M H, Qvamme, G M, Soee, K & Christiansen, P 2018, ' Male breast cancer : a nation-wide population-based comparison with female breast cancer ', Acta Oncologica, vol. 57, no. 5, pp. 613-621 . https://doi.org/10.1080/0284186X.2017.1418088
OBJECTIVE: Describe prognostic parameters of Danish male breast cancer patients (MBCP) diagnosed from 1980-2009. Determine all-cause mortality compared to the general male population and analyze survival/mortality compared with Danish female breast c
Autor:
Stephen Hamilton-Dutoit, Anders Kjærsgaard, Peer Christiansen, Marianne Ewertz, Rebecca A. Silliman, Henrik Toft Sørensen, Marco Mele, Deirdre Cronin-Fenton, Timothy L. Lash, Bent Ejlertsen, Thomas P. Ahern
Publikováno v:
Cronin-Fenton, D P, Kjærsgaard, A, Ahern, T P, Mele, M, Ewertz, M, Hamilton-Dutoit, S, Christiansen, P M, Ejlertsen, B, Sørensen, H T, Lash, T L & Silliman, R A 2017, ' Validity of Danish Breast Cancer Group (DBCG) registry data used in the predictors of breast cancer recurrence (ProBeCaRe) premenopausal breast cancer cohort study ', Acta Oncologica, vol. 59, no. 6, pp. 1155-1160 . https://doi.org/10.1080/0284186X.2017.1327720
Cronin-Fenton, D P, Kjærsgaard, A, Ahern, T P, Mele, M, Ewertz, M, Hamilton-Dutoit, S, Christiansen, P M, Ejlertsen, B, Sørensen, H T, Lash, T L & Silliman, R A 2017, ' Validity of Danish Breast Cancer Group (DBCG) registry data used in the predictors of breast cancer recurrence (ProBeCaRe) premenopausal breast cancer cohort study ', Acta Oncologica, vol. 56, no. 9, pp. 1155-1160 . https://doi.org/10.1080/0284186X.2017.1327720
Cronin-Fenton, D P, Kjærsgaard, A, Ahern, T P, Mele, M, Ewertz, M, Hamilton-Dutoit, S, Christiansen, P M, Ejlertsen, B, Sørensen, H T, Lash, T L & Silliman, R A 2017, ' Validity of Danish Breast Cancer Group (DBCG) registry data used in the predictors of breast cancer recurrence (ProBeCaRe) premenopausal breast cancer cohort study ', Acta Oncologica, vol. 56, no. 9, pp. 1155-1160 . https://doi.org/10.1080/0284186X.2017.1327720
BACKGROUND: Validation studies of the Danish Breast Cancer Group (DBCG) registry show good agreement with medical records for adjuvant treatment data, but inconsistent recurrence information. No studies have validated changes in menopausal status or
Autor:
Malgorzata K Tuxen, Mads K Hansen, M.H. Nielsen, Ilse Vejborg, Maj-Britt Jensen, Birgitte Vrou Offersen, Jens Overgaard, Bent Kristensen, Peer Christiansen, Henrik Flyger, Lisbet Rosenkrantz Hölmich, Anne-Marie Gerdes, Eva Balslev, Anne Vibeke Lænkholm, Henning T. Mouridsen, Bent Ejlertsen
Publikováno v:
Offersen, B V, Ejlertsen, B, Balslev, E, Flyger, H, Gerdes, A-M, Hansen, M K, Hølmich, L R, Jensen, M-B, Kristensen, B, Laenkholm, A-V, Mouridsen, H T, Nielsen, M H, Overgaard, J, Tuxen, M, Vejborg, I & Christiansen, P 2018, ' Is DBCG abreast of new developments? ', Acta Oncologica, vol. 57, no. 1, pp. 1-2 . https://doi.org/10.1080/0284186X.2017.1408960
The Danish Breast Cancer Group (DBCG) was established in 1977 by innovative and visionary clinicians and researchers diagnosing, treating and investigating breast cancer. The vision was to gather a...
Autor:
Bent Ejlertsen, Thomas P. Ahern, Uffe Heide-Jørgensen, Peer Christiansen, Deirdre P. Cronin-Fenton, Timothy L. Lash, Henrik Toft Sørensen
Publikováno v:
Cronin-Fenton, D P, Heide-Jørgensen, U, Ahern, T P, Lash, T L, Christiansen, P, Ejlertsen, B & Sørensen, H T 2016, ' Low-dose aspirin, non-steroidal anti-inflammatory drugs, selective COX-2 inhibitors and breast cancer recurrence ', Epidemiology . https://doi.org/10.1097/EDE.0000000000000480
BACKGROUND: Aspirin, non-steroidal anti-inflammatory drugs (NSAIDs), and selective COX-2 inhibitors may improve outcomes in breast cancer patients. We investigated the association of aspirin, NSAIDs, and use of selective COX-2 inhibitors with breast
Autor:
Anne, Bodilsen, Karsten, Bjerre, Birgitte V, Offersen, Pernille, Vahl, Nikolaj, Amby, J Michael, Dixon, Bent, Ejlertsen, Jens, Overgaard, Peer, Christiansen
Publikováno v:
Journal of surgical oncology. 113(6)
The association between margin width and ipsilateral breast tumour recurrence (IBTR, defined as invasive recurrence) was investigated in a population-based nationwide cohort of 11,900 patients undergoing breast-conserving therapy for invasive cancer.